Revenue

Moving beyond quick fixes, Alma unveils a continuous care strategy focused on long-term skin performance, signaling a major shift for the aesthetics industry.

Travelier's 12Go launches an AI app to book Asia's buses, trains, and ferries, aiming to digitize a fragmented market and change how we travel.

A new trade event in Kuala Lumpur signals China's shift from simple exports to a strategy of two-way investment and digital-physical market dominance.

A new partnership between OpenLegacy and Deloitte Tohmatsu offers a low-risk path for Japanese firms to modernize aging mainframes and avert a looming economic crisis.

A new powerhouse alumni of top marketers has launched, aiming to transform Hong Kong's sports scene into a major economic engine with innovative strategies.

Sweco reports stable Q1 growth amid a divided European market, leaning on infrastructure projects and key acquisitions to offset real estate sector weakness.

With gonorrhea becoming increasingly resistant to antibiotics, a new $2.6M grant fuels the development of a promising preventative vaccine platform.

A new platform offers one subscription for ChatGPT, Claude, and Gemini with an encrypted, user-owned memory that challenges the AI industry's data-hungry model.

Backed by activist investor Irenic Capital, a new $220M blank-check firm hits Nasdaq, aiming to acquire a target in the aerospace or industrial sectors.

Encoded Therapeutics is set to unveil pivotal data on ETX101, a one-time gene therapy showing promise in not just stopping seizures but reversing developmental delays.

Biotech firm Tr1X unveils promising data for its novel cell therapies, offering a scalable new approach to treating autoimmune diseases like MS and GvHD.

Dyno Therapeutics is using AI to design 'smart' viral vectors, promising safer, more effective treatments for untreatable genetic diseases.

Set to unveil its "best of both" PRINT™ platform, Addition Therapeutics aims to cure diseases from Fabry to HIV with a single, durable genetic medicine.

With its latest casino acquisition, the Snuneymuxw First Nation is becoming Canada's top Indigenous gaming operator, channeling profits into community prosperity.

After a major transformation, agilon health appoints a new CEO with deep payor and provider expertise to scale its value-based care model for seniors.

Cambridge biotech to unveil AI-powered LNP platform at ASGCT 2026, targeting fat and T-cells to unlock new treatments for obesity and cancer.

Umoja Biopharma's UB-VV500 aims to revolutionize myeloma care by creating a dual-antigen CAR T therapy directly inside the patient's body.

A new therapy programs immune cells inside the body to fight disease. Sail Biomedicines is pioneering this approach to offer a potential cure for autoimmunity.

Proptech giant SmartRent is moving beyond large complexes, launching a new program to bring smart home technology to millions of smaller rental properties.

The blank check company extends its merger deadline after an $850k sponsor deposit, facing a new owner, a cautious market, and a Nasdaq compliance notice.